These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 14098065)

  • 1. SPECIFIC VIRUS-NEUTRALIZING ACTIVITY OF SERA FROM CHICKS IMMUNIZED WITH POLIOVIRUSES.
    SLONIM D; DREVO M
    Acta Virol; 1963 Nov; 7():504-15. PubMed ID: 14098065
    [No Abstract]   [Full Text] [Related]  

  • 2. [ON THE VIABILITY AND RESISTANCE OF VACCINAL STRAINS OF POLIOVIRUSES IN THE EXTERNAL ENVIRONMENT].
    BYCHKOVSKAIA OV; BABINA NS; IVANOVA OD; KISELEVA LF
    Gig Sanit; 1964 Aug; 29():45-9. PubMed ID: 14249261
    [No Abstract]   [Full Text] [Related]  

  • 3. RESPONSE OF CHICKS TO POLIOVIRUS ANTIGENS.
    PRIER JE; SCHUCHARDT LS; MALSBERGER RG
    Public Health Rep (1896); 1963 Nov; 78(11):1005-9. PubMed ID: 14084867
    [No Abstract]   [Full Text] [Related]  

  • 4. SERODIFFERENTIATION BETWEEN TYPE 1 POLIOVIRUSES WITH ANTISERA PRODUCED IN RABBITS USING FOUR DIFFERENT IMMUNIZATION SCHEMES.
    SIBONI K; VON MAGNUS
    Acta Pathol Microbiol Scand; 1963; 58():376-84. PubMed ID: 14044676
    [No Abstract]   [Full Text] [Related]  

  • 5. ANTIGENIC DIFFERENTIATION OF POLIOVIRUSES BY ABSORBED HYPERIMMUNE SERA. I. ANTIGENIC DIFFERENTIATION OF TYPE I STRAINS OF DIVERSE ORIGIN.
    EYLAN E; FOGEL A; DUKLER R; RANNON L
    J Immunol; 1965 Jul; 95():171-80. PubMed ID: 14328695
    [No Abstract]   [Full Text] [Related]  

  • 6. THE FORMATION AND PROPERTIES OF POLIOVIRUS-NEUTRALIZING ANTIBODY. IV. NORMAL ANTIBODY AND EARLY IMMUNE ANTIBODY OF RABBIT ORIGIN: A COMPARISON OF BIOLOGICAL AND PHYSICOCHEMICAL PROPERTIES.
    SVEHAG SE
    J Exp Med; 1964 Apr; 119(4):517-35. PubMed ID: 14151096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ANTIGENIC VARIATIONS AMONG TYPE III POLIOMYELITIS VIRUSES.
    DEIBEL R; MACDONALD D
    N Y State J Med; 1964 Aug; 64():2058-65. PubMed ID: 14180893
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparative study of antibody levels developed by vaccination against polio virus in population after vaccine type alteration.
    Farkas Á; Magyar N; Szomor KN; Takács M
    Acta Microbiol Immunol Hung; 2015 Mar; 62(1):75-85. PubMed ID: 25823455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A COMPARISON OF THE REACTIVITY OF POLIOVIRUS COMPLEMENT-FIXING ANTIGENS (NATIVE, HEATED AND SUCROSE DENSITY GRADIENT C AND D) WITH HUMAN SERA.
    LENNETTE EH; SCHMIDT NJ; MAGOFFIN RL; HAGENS SJ; DUKELLIS EJ
    J Immunol; 1964 Feb; 92():261-74. PubMed ID: 14160447
    [No Abstract]   [Full Text] [Related]  

  • 10. A SERUM INHIBITOR IN ANIMAL AND HUMAN SERA OF BOVINE ENTEROVIRUSES. II. IN VIVO ACTIVITY AND ROLE IN "NATURAL" RESISTANCE TO INFECTION.
    KLEIN M; DEFOREST A
    J Immunol; 1964 May; 92():822-6. PubMed ID: 14170425
    [No Abstract]   [Full Text] [Related]  

  • 11. ELISA as a possible alternative to the neutralization test for evaluating the immune response to poliovirus vaccines.
    Ivanov AP; Dragunsky EM
    Expert Rev Vaccines; 2005 Apr; 4(2):167-72. PubMed ID: 15889990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repertoire of antibodies against type 1 poliovirus in human sera.
    Rezapkin G; Neverov A; Cherkasova E; Vidor E; Sarafanov A; Kouiavskaia D; Dragunsky E; Chumakov K
    J Virol Methods; 2010 Nov; 169(2):322-31. PubMed ID: 20691212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MARKER TEST OF POLIOVIRUS IN RELATION TO MASS VACCINATION WITH LIVE ORAL VACCINES.
    TOYOSHIMA K; MITSUDA B; TADOKORO J; YAMADA T; KUNITA N
    Biken J; 1963 Jul; 6():57-72. PubMed ID: 14147706
    [No Abstract]   [Full Text] [Related]  

  • 14. [ANTIBODY LEVELS IN VITAMIN A DEFICIENCY IN CHICKS IMMUNIZED WITH AN ANTIGEN FROM THE NEMATODE ASCARIDIA GALLI].
    LEUTSKAIA ZK
    Dokl Akad Nauk SSSR; 1964 Dec; 159():938-40. PubMed ID: 14311052
    [No Abstract]   [Full Text] [Related]  

  • 15. [RESEARCH ON AN ATTENUATED VIRUS OF INFECTIOUS BRONCHITIS IN CHICKENS. IV. PRODUCTION OF SERO-NEUTRALIZING ANTIBODIES IN VACCINATED ANIMALS].
    SCHIAVO A
    Boll Soc Ital Biol Sper; 1963 Nov; 39():1347-50. PubMed ID: 14123607
    [No Abstract]   [Full Text] [Related]  

  • 16. A human-human hybridoma which produces antibodies to polioviruses.
    Chu CT; Yang SY; Yang CS
    Proc Natl Sci Counc Repub China B; 1989 Oct; 13(4):284-8. PubMed ID: 2561573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistence of poliovirus neutralizing antibodies eight years after immunization with live, attenuated-virus vaccine.
    Rousseau WE; Noble GR; Tegtmeier GE; Jordan MC; Chin TD
    N Engl J Med; 1973 Dec; 289(25):1357-9. PubMed ID: 4356637
    [No Abstract]   [Full Text] [Related]  

  • 18. [Findings of virus-neutralizing antibodies against polioviruses in the population of Slovakia 9 and 12 years following introduction of immunization by attenuated polioviruses (author's transl)].
    Borská K; Mayerová A; Masár I; Svanigová L; Roda J; Lukácová V
    Bratisl Lek Listy; 1976 Apr; 65(4):400-6. PubMed ID: 183864
    [No Abstract]   [Full Text] [Related]  

  • 19. Global eradication of poliomyelitis: reinvent the wheel or use existing options effectively?
    Ogra PL
    Public Health Rev; 1993-1994; 21(1-2):143-50. PubMed ID: 8041881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A note on single- and two-dose immunogenicity tests of inactive virus vaccine in chicks.
    Slonim D; Drevo M
    J Hyg Epidemiol Microbiol Immunol; 1976; 21(3):368-70. PubMed ID: 1033226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.